Your browser doesn't support javascript.
loading
Adherence to Guideline-Recommended cancer screening among Utah cancer survivors.
Millar, Morgan M; Edwards, Sandra L; Herget, Kimberly A; Orleans, Brian; Ofori-Atta, Blessing S; Kirchhoff, Anne C; Carter, Marjorie E; Nagata, Marie; Sweeney, Carol.
Afiliação
  • Millar MM; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA.
  • Edwards SL; Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
  • Herget KA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Orleans B; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA.
  • Ofori-Atta BS; Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA.
  • Kirchhoff AC; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Carter ME; Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
  • Nagata M; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Sweeney C; Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
Cancer Med ; 12(3): 3543-3554, 2023 02.
Article em En | MEDLINE | ID: mdl-36029153
ABSTRACT

BACKGROUND:

Adherence to cancer screening is important for cancer survivors because they are at high risk of subsequent cancer diagnoses or recurrence. We assessed adherence to breast, cervical, and colorectal cancer-(CRC)-screening guidelines and evaluated demographic disparities among a population-based sample of survivors.

METHODS:

A representative sample of Utah survivors diagnosed from 2012-2018 with any reportable invasive cancer was selected from central cancer registry records for a survey about survivorship needs. We estimated the proportion of eligible survivors adhering to U.S. Preventive Services Task Force screening guidelines and calculated risk ratios and 95% confidence intervals. Analyses were age-adjusted and weighted to account for sample design and nonresponse.

RESULTS:

And 1421 survivors completed the survey (57.2% response rate). Screening adherence was 74.4% for breast, 69.4% for cervical, and 79.7% for CRC. Rural residents were more likely to adhere to breast cancer screening than urban residents (86.1% vs. 72.7%; adjusted RR = 1.19, CI = 1.05, 1.36). Higher educational attainment was associated with increased adherence to cervical and colorectal cancer screening. Younger age was associated with greater adherence to cervical cancer screening (p = 0.006) but lower adherence to CRC screening (p = 0.003). CRC screening adherence was lower among the uninsured and those without a primary care provider (45.6%) compared to those with a regular provider (83.0%; adjusted RR = 0.57, CI = 0.42, 0.79).

CONCLUSIONS:

Surveys based on samples from central cancer registries can provide population estimates to inform cancer control. Findings demonstrate work is needed to ensure all Utah cancer survivors obtain recommended cancer screenings. Efforts should focus particularly on increasing uptake of breast and cervical cancer screening and reducing demographic disparities in CRC screening. PRECIS Despite high risk for subsequent cancer diagnosis, Utah cancer survivors are not all obtaining recommended breast, cervical, and colorectal cancer screenings. This presents a significant healthcare gap.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo do Útero / Sobreviventes de Câncer Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo do Útero / Sobreviventes de Câncer Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Limite: Female / Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA